Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models.

Raab, Monika; Becker, Sven; Kressin, Monika; Strebhardt, Klaus; Pena-Llopis, Samuel; Sanhaji, Mourad; Gasimli, Khayal; Kolaric, Margareta; Győrffy, Balázs; Fietz, Daniela; Ebert, Matthias

doi:10.1002/cac2.70029

%0 Journal Article
%A Raab, Monika
%A Győrffy, Balázs
%A Pena-Llopis, Samuel
%A Fietz, Daniela
%A Kressin, Monika
%A Kolaric, Margareta
%A Ebert, Matthias
%A Gasimli, Khayal
%A Becker, Sven
%A Sanhaji, Mourad
%A Strebhardt, Klaus
%T Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models.
%J Cancer communications
%V 45
%N 8
%@ 1000-467X
%C Hoboken, NJ
%I Wiley
%M DKFZ-2025-01049
%P 966-970
%D 2025
%Z Volume 45, Issue 8 pp. 966-970
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40391786
%R 10.1002/cac2.70029
%U https://inrepo02.dkfz.de/record/301510

guest :: login DKFZ
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help